Opportunity Information: Apply for W81XWH 10 NFRP NIA
Apply for W81XWH 10 NFRP NIA
- The Dept. of the Army USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Neurofibromatosis New Investigator Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420 Military Medical Research and Development.
- This funding opportunity was created on Mar 2, 2010 and posted on Mar 2, 2010.
- Applicants must submit their applications by May 20, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $1,800,000.00 to eligible and selected applicants.
- The number of recipients for this funding is limited to 3 candidate(s).
- Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The DoD Neurofibromatosis New Investigator Award (NIA) is a funding opportunity under the Department of Defense Neurofibromatosis Research Program (NFRP) designed to help promising early-stage, independent researchers build or strengthen their careers in neurofibromatosis (NF) research. First introduced in FY1999, the program has a track record that shows it is competitive but established: 179 applications had been received over time, with 38 recommended for funding. The central goal is career transition and continued development, meaning it is aimed at investigators who are ready to lead their own NF-focused projects and establish themselves as independent contributors to the field.
A key feature of this award is that prior NF experience is allowed but not required. That makes it accessible to strong investigators coming from related disciplines who want to pivot into NF research. At the same time, the program signals that applicants without deep NF background should partner with a collaborator who has demonstrated NF expertise, which helps ensure the project is grounded in the realities of NF biology, clinical care, and the needs of the patient community. Another non-negotiable requirement is that applications must include preliminary data that relate to NF and to the proposed work. That preliminary evidence can come from the principal investigator, the research team, or a collaborator, but it needs to show that the approach is feasible and connected to NF in a concrete way.
For FY2010, the opportunity specifically encourages proposals that target urgent and practical needs in the NF community. One priority area is complications associated with high mortality, including cancers or tumor-related disease (neoplasms) and cerebrovascular abnormalities. A second priority area focuses on complications that may not be as immediately life-threatening but cause major long-term disability or reduced functioning (high morbidity). Examples listed include skeletal problems, learning deficits, hormone-associated effects, and pain, all of which can significantly impact daily life and long-term outcomes for people living with NF. A third encouraged area is the refinement and standardization of tools needed to make future clinical trials stronger and more comparable across sites, such as imaging techniques, molecular and cellular markers, and quality-of-life metrics. A fourth area emphasizes translational research, particularly the development of therapeutic candidates or preclinical testing of potential treatments, reflecting an interest in moving discoveries toward real-world interventions even if the work is not yet at the stage of testing in patients.
Human subjects research is permitted under this mechanism, but clinical trials are explicitly not allowed. The announcement uses a standard definition of a clinical trial as a prospective study in which an intervention (such as a drug, device, behavioral program, surgery, or similar) is tested in human subjects to measure an outcome. Applicants who want to run a clinical trial are directed instead to the FY2010 NFRP Clinical Trial Award mechanism. The notice also points applicants to the program’s general application instructions for rules and expectations related to human subjects, human data, or human anatomical substances, which suggests that compliance, ethical review, and proper handling of human-derived materials are taken seriously even when a project stops short of an interventional trial.
Administratively, this opportunity was posted March 2, 2010, with a closing date of May 20, 2010, and it was run by the Department of the Army through USAMRAA. The funding instrument types listed include cooperative agreement and grant, and the activity category is science and technology and other research and development. The program anticipated making about three awards, with an estimated total funding pool of $1.8 million, and it did not require cost sharing or matching funds. Eligibility was described as unrestricted, meaning a wide range of applicant organizations could apply, subject to any additional clarifications in the full announcement. The opportunity is associated with CFDA 12.420 (Military Medical Research and Development) and carried the funding opportunity number W81XWH-10-NFRP-NIA. Contact resources were provided through CDMRP support channels for technical issues accessing the announcement or using the electronic submission systems.
DoD Neurofibromatosis New Investigator Award (NIA) FAQ
What is the DoD Neurofibromatosis New Investigator Award (NIA)?
The Neurofibromatosis New Investigator Award (NIA) is a funding opportunity under the Department of Defense Neurofibromatosis Research Program (NFRP). It is designed to help promising early-stage, independent researchers build or strengthen their careers in neurofibromatosis (NF) research by leading NF-focused projects as independent contributors.
What is the main purpose of this award?
The central goal is career transition and continued development. The award targets investigators who are ready to lead their own NF-focused research and establish themselves as independent researchers in the field.
When was the NIA first introduced?
The NIA mechanism was first introduced in FY1999.
How competitive is this opportunity based on the program track record described?
The program is described as competitive but established. Over time, 179 applications were received, and 38 were recommended for funding.
Is prior neurofibromatosis (NF) research experience required to apply?
No. Prior NF experience is allowed but not required, which makes the award accessible to strong investigators from related disciplines who want to pivot into NF research.
If an applicant does not have deep NF experience, is collaboration expected?
Yes. The program indicates that applicants without a deep NF background should partner with a collaborator who has demonstrated NF expertise. This is intended to ensure the project is grounded in NF biology, clinical care, and patient community needs.
Is preliminary data required for an application?
Yes. Applications must include preliminary data related to NF and to the proposed work. This is described as a non-negotiable requirement.
Whose preliminary data can be used to meet the requirement?
The preliminary evidence can come from the principal investigator, the research team, or a collaborator, as long as it relates to NF and supports the feasibility and NF relevance of the proposed approach.
What research areas were specifically encouraged for FY2010?
For FY2010, proposals were encouraged to address urgent and practical needs in the NF community, including: (1) high-mortality complications such as cancers or tumor-related disease (neoplasms) and cerebrovascular abnormalities; (2) high-morbidity complications that drive long-term disability or reduced functioning, including skeletal problems, learning deficits, hormone-associated effects, and pain; (3) refinement and standardization of tools that strengthen future clinical trials (for example, imaging techniques, molecular and cellular markers, and quality-of-life metrics); and (4) translational research, including development of therapeutic candidates or preclinical testing of potential treatments.
Does the opportunity allow research involving human subjects?
Yes. Human subjects research is permitted under this mechanism.
Are clinical trials allowed under the NIA mechanism?
No. Clinical trials are explicitly not allowed under this award mechanism.
How does the announcement define a clinical trial in this context?
A clinical trial is described as a prospective study in which an intervention (such as a drug, device, behavioral program, surgery, or similar) is tested in human subjects to measure an outcome.
If an applicant wants to run a clinical trial, where should they apply instead?
Applicants who want to run a clinical trial are directed to the FY2010 NFRP Clinical Trial Award mechanism rather than the NIA.
Are there additional rules for projects involving human data or human anatomical substances?
Yes. The notice points applicants to the program's general application instructions for rules and expectations related to human subjects, human data, or human anatomical substances, indicating compliance and proper handling requirements apply even when the work is not a clinical trial.
Who administered this opportunity?
The opportunity was run by the Department of the Army through USAMRAA.
What were the posting and closing dates for the FY2010 opportunity?
The opportunity was posted on March 2, 2010, and the closing date was May 20, 2010.
What types of funding instruments were listed?
The listed funding instrument types included a cooperative agreement and a grant.
What was the activity category for this opportunity?
The activity category was listed as science and technology and other research and development.
How many awards were anticipated and what was the estimated total funding amount?
The program anticipated making about three awards, with an estimated total funding pool of $1.8 million.
Was cost sharing or matching funds required?
No. The opportunity did not require cost sharing or matching funds.
Who was eligible to apply?
Eligibility was described as unrestricted, meaning a wide range of applicant organizations could apply, subject to any additional clarifications in the full announcement.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 12.420 (Military Medical Research and Development).
What is the funding opportunity number for the FY2010 NIA?
The funding opportunity number is W81XWH-10-NFRP-NIA.
Where could applicants get help with technical issues related to the announcement or electronic submission?
Contact resources were provided through CDMRP support channels for technical issues accessing the announcement or using the electronic submission systems.
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoD Neurofibromatosis Exploration Hypothesis Development Award
Previous opportunity: Fish and Wildlife Coordination Act Program Yuma Area
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for W81XWH 10 NFRP NIA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (W81XWH 10 NFRP NIA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoD Neurofibromatosis Exploration Hypothesis Development Award Apply for W81XWH 10 NFRP EHDA Funding Number: W81XWH 10 NFRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Tuberous Sclerosis Complex Exploration Hypothesis Development Award Apply for W81XWH 10 TSCRP EHDA Funding Number: W81XWH 10 TSCRP EHDA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Tuberous Sclerosis Complex Career Transition Award Apply for W81XWH 10 TSCRP CARTA Funding Number: W81XWH 10 TSCRP CARTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Laboratory Clinical Transition Award Apply for W81XWH 10 PCRP LCTA Funding Number: W81XWH 10 PCRP LCTA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoD Prostate Cancer Population Based Research Award Apply for W81XWH 10 PCRP PBRA Funding Number: W81XWH 10 PCRP PBRA Agency: Dept. of the Army USAMRAA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Office Wide Broad Agency Announcement Microsystems Technology Office Apply for DARPA BAA 10 35 Funding Number: DARPA BAA 10 35 Agency: DARPA Microsystems Technology Office Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Research in Innovative Approaches to Fusion Energy Sciences Apply for DE FOA 0000286 Funding Number: DE FOA 0000286 Agency: Chicago Service Center Category: Science and Technology and other Research and Development Funding Amount: $1,700,000 |
| George Mason University Center for Infrastructure Protection Apply for 2010 CIP 06 Funding Number: 2010 CIP 06 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| University of Hawaii, Hawaii Open Supercomputing Center Apply for 2010 CIP 08 Funding Number: 2010 CIP 08 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| University of Kentucky Firefighter Gear Safety Research Program Apply for 2010 CIP 09 Funding Number: 2010 CIP 09 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| University of Maryland Baltimore County Maryland Center of Excellence for Terahertz Science and Application Apply for 2010 CIP 10 Funding Number: 2010 CIP 10 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| University of Rhode Island Rhode Island Consortium for Nanoscience and Nanotechnology Apply for 2010 CIP 11 Funding Number: 2010 CIP 11 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Agile Delivery of Electrical Power Technology (ADEPT) Apply for DE FOA 0000288 Funding Number: DE FOA 0000288 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 |
| University at Albany (SUNY) New York Center for National Competitiveness in Nanoscale Characterization at the College of Nanoscale Science and Engineering (CNSE) Apply for 2010 CIP 05 Funding Number: 2010 CIP 05 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Building Energy Efficiency Through Innovative Thermodevices (BEETIT) Apply for DE FOA 0000289 Funding Number: DE FOA 0000289 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 |
| Gridscale Rampable Intermittently Dispatchable Storage (GRIDS) Apply for DE FOA 0000290 Funding Number: DE FOA 0000290 Agency: Headquarters Category: Science and Technology and other Research and Development Funding Amount: $10,000,000 |
| North Dakota State University Advanced Nanomaterials Research Facility Apply for 2010 CIP 04 Funding Number: 2010 CIP 04 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| University of Alabama Interdisciplinary Science and Engineering Teaching and Research Corridor Apply for 2010 CIP 01 Funding Number: 2010 CIP 01 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| University of Mississippi Medical Center The Mississippi Biotechnology Research Park Apply for 2010 CIP 02 Funding Number: 2010 CIP 02 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| Mississippi State University Expansion of the Research, Technology and Economic Development Park Apply for 2010 CIP 03 Funding Number: 2010 CIP 03 Agency: National Institute of Standards and Technology Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "W81XWH 10 NFRP NIA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
